Updates are available Correction dated 2018-06-27
Click to view Correction: https://doi.org/10.1007/s00380-018-1212-7
-
Authors
An, Yoshimori
Esato, Masahiro
Ishii, Mitsuru
Iguchi, Moritake
Masunaga, Nobutoyo
Tsuji, Hikari
Wada, Hiromichi
Hasegawa, Koji
Ogawa, Hisashi
Abe, Mitsuru
Lip, Gregory Y. H.
Akao, Masaharu
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Astellas Pharma, AstraZeneca, Daiichi Sankyo, Novartis Pharma, MSD, Sanofi-Aventis and Takeda Pharmaceutical.
- License Information
-
More Information
Article History
Received: 16 February 2018
Accepted: 18 May 2018
First Online: 24 May 2018
Change Date: 27 June 2018
Change Type: Correction
Change Details: In the original publication of the article, the data of Body mass index ≥ 25 (kg/m ) is published incorrectly in Table 1. Since this is categorical variable, the data should have been expressed as a number (percentage), not as mean ± standard deviation. The corrected version of Table 1 is as below,
Compliance with ethical standards
:
: Dr. Akao received lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Healthcare and Daiichi Sankyo. Dr Lip has served as a consultant for Bayer, Merck, Sanofi, BMS/Pfizer, Daiichi Sankyo, Biotronik, Medtronic, Portola and Boehringer Ingelheim and has been on the speakers bureau for Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
